about
Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitusPredetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety.Prevalence of short stature, underweight, overweight, and obesity among school children in JordanSmokers' hair: Does smoking cause premature hair graying?UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population.Self-medication patterns in Amman, Jordan.The effects of caudal or intravenous dexmedetomidine on postoperative analgesia produced by caudal bupivacaine in children: a randomized controlled double-blinded study.Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients.Validation of a comprehensive classification tool for treatment-related problems.Population pharmacokinetic analysis of clopidogrel in healthy Jordanian subjects with emphasis optimal sampling strategy.Management of hypertension and factors affecting its control in Jordanian renal transplant recipients.Lack of Association between CYP1A1 M2 and M4 Polymorphisms and Breast Carcinoma in Jordanian Women: a Case-Control Study.Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.Recurrent ecchymoses after acute tacrolimus intoxication.Abuse and misuse of prescription and nonprescription drugs sold in community pharmacies in Jordan.SERUM LEVELS OF CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH TYPE 2 DIABETES.Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study.Adverse effects of tacrolimus in renal transplant patients from living donors.The prevalence of isolated growth hormone deficiency among children of short stature in Jordan and its relationship with consanguinity.Ligand-based designing, in silico screening, and biological evaluation of new potent fructose-1,6-bisphosphatase (FBPase) inhibitors.Lipid and hematological parameters in hyperleptinemic healthy Arab male youth in Jordan.Incidence of bcr‑abl fusion transcripts in healthy individuals.An innovative pharmaceutical care practical courseBerberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validationCommunity consumption of antibacterial drugs within the Jordanian population: sources, patterns and appropriatenessCyclooxygenase-2 (COX2) gene polymorphisms and the risk of sporadic colorectal cancer and polyps among Jordanian populationThe association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancerFolate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemiaEarly disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapyComprehensive assessment of treatment related problems in hospitalized medicine patients in JordanFood-drug interactions: Knowledge among pharmacists in Jordan
P50
Q28222564-A882854E-9405-40C1-915C-C718CC59C987Q33889887-AB9A23EF-2479-44C0-8637-836972FF3A99Q36156905-AD48ABB7-7549-46BB-99FE-E1BC5FF47B30Q36904755-6126776C-0645-437E-A454-FDA8E9D326CBQ39647877-D9F5C91E-2443-4033-9856-723ADE239B21Q40204635-E96AF5B8-1127-4448-A0DD-B860E45C70B9Q40609868-91FB910C-326E-4E9B-BEB6-CE71FD767C43Q40735607-DB650977-C03A-424D-978E-F9C42F6D5994Q42601849-2518203A-84B7-4F1F-85D7-058ACDA3C2B5Q44165413-A0D6A85A-EAAC-4C95-ABE9-E6925F1F4E92Q44190918-8E22D242-1253-4E7C-9320-98F3B3FB646BQ46482614-18FEE427-B1F8-48D0-ADF5-C428A0FABF65Q46493342-B020560A-9640-4474-8656-D85638C20068Q46544531-3433D841-C4F7-40F0-888F-B64F056608ECQ46678656-BE411750-0B62-4EE3-B9C0-EF094B13513FQ47725861-C960506C-A64B-4EFF-9A91-65D4D8B5CF4AQ49993868-DBF5BCAF-2F11-42E3-8A22-29B1B693553DQ50266059-7D30B804-5469-4285-9E19-080FEB5C28EFQ50655459-D3761811-798D-41A0-904A-B801BFFD1F67Q50913121-986B1B7B-C2C8-4F1E-B1F7-51E920B14D1AQ51369000-B1E6065C-D563-4546-8A09-54A1B35E2C1BQ54376567-26D94962-E30E-415E-BE45-B0E25CA4421EQ79242538-4F7F625C-4DAB-4ECF-9706-01C4EF31CC6DQ79763647-DA519A2A-69C8-41DC-BDE0-852DA331C18FQ81344532-FFB0D56A-E97A-4E60-9216-3C9F557C77FAQ87041582-96E69FC0-2E88-4A28-B6E4-D1326ED39D5EQ88913034-C2746E0E-3D05-4102-8800-C339B0D57A23Q91229812-70E5412F-A77E-4AC1-9A82-5568894E3787Q91399365-9849AD09-51D0-4646-ACD3-CFA60C4C4689Q95474980-4CF8CFFF-B93D-4871-8F70-D41D7B6FF4D1Q96577990-99E7E025-3897-4891-9C77-1BF9BAC7906A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Al-Motassem F Yousef
@ast
Al-Motassem F Yousef
@en
Al-Motassem F Yousef
@es
Al-Motassem F Yousef
@nl
type
label
Al-Motassem F Yousef
@ast
Al-Motassem F Yousef
@en
Al-Motassem F Yousef
@es
Al-Motassem F Yousef
@nl
prefLabel
Al-Motassem F Yousef
@ast
Al-Motassem F Yousef
@en
Al-Motassem F Yousef
@es
Al-Motassem F Yousef
@nl
P106
P1153
8847282700
P31
P496
0000-0002-3841-4132